De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.
- DOI
- 10.1093/brain/awae409
- Published
- 2025 May 13
- Container
- Brain : a journal of neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/brain/awae409,
title = {De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.},
author = {Androdias G and Lünemann JD and Maillart E and Amato MP and Audoin B and Bruijstens AL and Bsteh G and Butzkueven H and Ciccarelli O and Cobo-Calvo A and Derfuss T and Di Pauli F and Edan G and Enzinger C and Geraldes R and Granziera C and Hacohen Y and Hartung HP and Hynes S and Inglese M and Kappos L and Kuusisto H and Langer-Gould A and Magyari M and Marignier R and Montalban X and Mycko MP and Nourbakhsh B and Oh J and Oreja-Guevara C and Piehl F and Prosperini L and Sastre-Garriga J and Sellebjerg F and Selmaj K and Siva A and Tallantyre E and van Pesch V and Vukusic S and Weinstock-Guttman B and Zipp F and Tintoré M and Iacobaeus E and Stankoff B},
year = {2025},
journal = {Brain : a journal of neurology},
doi = {10.1093/brain/awae409},
url = {https://doi.org/10.1093/brain/awae409}
}RIS
TY - JOUR TI - De-escalating and discontinuing disease-modifying therapies in multiple sclerosis. AU - Androdias G AU - Lünemann JD AU - Maillart E AU - Amato MP AU - Audoin B AU - Bruijstens AL AU - Bsteh G AU - Butzkueven H AU - Ciccarelli O AU - Cobo-Calvo A AU - Derfuss T AU - Di Pauli F AU - Edan G AU - Enzinger C AU - Geraldes R AU - Granziera C AU - Hacohen Y AU - Hartung HP AU - Hynes S AU - Inglese M AU - Kappos L AU - Kuusisto H AU - Langer-Gould A AU - Magyari M AU - Marignier R AU - Montalban X AU - Mycko MP AU - Nourbakhsh B AU - Oh J AU - Oreja-Guevara C AU - Piehl F AU - Prosperini L AU - Sastre-Garriga J AU - Sellebjerg F AU - Selmaj K AU - Siva A AU - Tallantyre E AU - van Pesch V AU - Vukusic S AU - Weinstock-Guttman B AU - Zipp F AU - Tintoré M AU - Iacobaeus E AU - Stankoff B PY - 2025 JO - Brain : a journal of neurology DO - 10.1093/brain/awae409 UR - https://doi.org/10.1093/brain/awae409 ER -
APA
G, A., JD, L., E, M., MP, A., B, A., AL, B., G, B., H, B., O, C., A, C., T, D., F, D. P., G, E., C, E., R, G., C, G., Y, H., HP, H., S, H., M, I., L, K., H, K., A, L., M, M., R, M., X, M., MP, M., B, N., J, O., C, O., F, P., L, P., J, S., F, S., K, S., A, S., E, T., V, V. P., S, V., B, W., F, Z., M, T., E, I., & B, S. (2025). De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.. Brain : a journal of neurology. https://doi.org/10.1093/brain/awae409
Source records
- pubmed · retrieved 2026-09-26T15:45:49.670Z